Your location:Home > Company Profile > 资质证书
Company Profile

资质证书


 1、公司现有印迹基因相关国内专利17项,国际专利18项,共涉及12种肿瘤。

 专利.png

2、学术活动:

国际会议壁报交流:

ATA (1 abstract) 美国甲状腺年会

Rulong Shen, et al: Epigenetic Panel of Imprinted Genes Can Enhance the Accuracy of FNA Cytopathology for Thyroid Cancer. American Thyroid Association 2019 Annual Meeting, Poster Presentation, Oct 31, 2019

WCLC (2 abstracts)世界肺癌大会

Jian Zhou, et al: Imprinted Genes Predict Non-small Cell Lung Cancer Prognosis. World Conference for Lung Cancers 2019, Poster Presentation, Sep 7, 2019 Rex Yung, et al: In-situ Hybridization Visual Scoring of Epigenetic Imprinting Genes Improves Early Diagnosis and Grading of Lung Cancers. World Conference for Lung Cancers 2019, Poster Presentation, Sep 7, 2019

CSCO (2 abstract)中国肿瘤年会

Ning Zhou, et al: Epigenetic Imprinted Genes Can Be Used as Biomarkers for Malignant Tumors. 2019 Chinese Society of Clinial Oncology (CSCO) Annual Meeting, Poster Presentation, Sep 18, 2019 Jian Zhou, et al: A Panel of Novel Epigenetic Imprinted Genes Improves Early Diagnosis of Lung Cancers. 2019 Chinese Society of Clinial Oncology (CSCO) Annual Meeting, Poster Presentation, Sep 18, 2019

USCAP (1 abstract)美国病理年会

Rulong Shen, et al: A Quantitative Chromogenic Technique for Imprinted Gene In Situ Hybridization (IG-ISH) -A New Addition for Enhanced Accuracy in Presurgical Diagnosis of Thyroid Cancers. United States and Canadian Academy of Pathology 109th Annual Meeting, Abstract, Feb 29, 2020


3、国际大会演讲:

Chunxue Bai, et al: Imprinting Diagnostics for Evaluation of Early Stage Lung Cancers. 2018  International Symposium on Respiratory Diseases (ISRD)& American Thoracic Society (ATS) Joint Conference: Oral Presentation, Nov 16, 2018 Chunxue Bai, et al: Novel Epigenetic Bio-markers for Lung Cancers. American Thoracic Society 2019 International Conference: Oral Presentation, May 18, 2019 Rex Yung, et al: ISH Chromogenic Staining Non-Coding Nascent RNA for Detection of Lung Cancer Imprinting Genes. 2019 Lung Cancer SPORE: Oral Presentation, June 13, 2019


4、SCI文章投稿:

Rulong Shen, et al: Aberrant Expression Status of Imprinted Genes as Novel Epigenetic Cancer Biomarkers. in submission Jian Zhou, et al: Intronic non-coding RNAs of imprinted genes LSID001, LSID011, LSID016 and LSID019 as early lung cancer diagnostic biomarkers. in manuscript Jian Zhou, et al: An Epigenetic Panel of Imprinted Genes for Non-Small Cell Lung Cancer Prognosis. in manuscript